California law banning drug coupons failed to increase generic use

A California’s law banning coupons for brand-name prescription drugs has not dramatically increased the use of cheaper generics in its first year, new analysis shows.

the law, which took effect in January 2018, was one of several attempts by state officials to control the rising cost of prescription drugs. Coupons have been an attractive target. Drugmakers claim they are cutting consumer spending, but critics say coupons are clever marketing tools used to promote more expensive drugs and ultimately cost the overall healthcare system more.

Unlock this article by subscribing to STAT + and enjoy your first 30 days free!


What is that?

STAT + is STAT’s premium subscription service for in-depth coverage and analysis of biotechnology, pharmaceuticals, policy and life sciences. Our award-winning team covers the news on Wall Street, policy developments in Washington, early scientific breakthroughs and clinical trial results, as well as healthcare disruptions in Silicon Valley and beyond.

What is included?

  • Daily reporting and analysis
  • Industry’s most comprehensive coverage from a powerful team of journalists
  • Newsletters reserved for subscribers
  • Daily newsletters to keep you informed of the most important industry news of the day
  • STAT + conversations
  • Weekly opportunities to engage with our journalists and leading industry experts in live video chats
  • Exclusive industry events
  • Premium access to subscriber-only networking events nationwide
  • The best reporters in the industry
  • The most reliable and most connected newsroom in healthcare
  • And much more
  • Exclusive interviews with industry leaders, profiles and premium tools, like our CRISPR Trackr.

Source link

Previous New Mexico governor, legislature legalizes adult cannabis
Next Talking huge with Craig Golias

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *